MedPath

Ranitidine Hydrochloride Oral Suspension Kit

Ranitidine Hydrochloride Oral Suspension Pineapple/Orange Oral Suspension Kit Repackaged 70332-109

Approved
Approval ID

6209ffbb-d544-23e4-e053-2991aa0abfa3

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 5, 2018

Manufacturers
FDA

California Pharmaceuticals, LLC

DUNS: 021420944

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

RANITIDINE HYDROCHLORIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70332-109
Product Classification
G
Generic Name
RANITIDINE HYDROCHLORIDE
Product Specifications
Effective DateJanuary 5, 2018
FDA Product Classification

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Ranitidine Hydrochloride Oral Suspension Kit - FDA Drug Approval Details